SHE:300558

2 stories mentioning SHE:300558Updated just now

Every FINWIRES story that references SHE:300558, newest first.

Betta Pharmaceuticals Gets Nod to Register Bemena As Lung Cancer Drug

Betta Pharmaceuticals (SHE:300558) received a drug registration certificate from China's National Medical Products Administration for ensartinib hydrochloride capsules, which trades as Bemena, according to a Shenzhen bourse disclosure published late Thursday.The certificate is for the drug's indication as a treatment for patients with anaplastic lymphoma kinase-positive stage IB to stage IIIB non-small cell lung cancer who have previously undergone surgical resection.

SHE:300558

Asia4d ago

Betta Pharmaceuticals Resubmits Hong Kong Listing Application

Betta Pharmaceuticals (SHE:300558) resubmitted its application to offer and list shares on the Hong Kong Stock Exchange on Aug. 28, according to a Monday disclosure on the Shenzhen bourse.The Chinese pharmaceutical company's shares fell 2% during the afternoon trade.

SHE:300558

Track with the FINWIRES app suite

FolioX

Track SHE:300558 in your portfolio

WheelAI

Analyze SHE:300558 options with the wheel strategy

StockInsider

See market sentiment on SHE:300558